Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease?

MOspace/Manakin Repository

Breadcrumbs Navigation

Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/2803

[-] show simple item record

dc.contributor.author Stevermer, James J.
dc.date.accessioned 2009-10-01T20:21:26Z
dc.date.available 2009-10-01T20:21:26Z
dc.date.issued 2001-02 en
dc.identifier.uri http://hdl.handle.net/10355/2803
dc.description.abstract The primary motivation to screen asymptomatic women after a hysterectomy is to prevent morbidity and mortality from gynecologic cancer. However, primary vaginal cancer is rare, the vaginal Pap test is not particularly accurate, and the natural history of precancerous vaginal lesions is uncertain. Based on these facts there is no compelling reason to screen women after hysterectomy for benign disease with routine Pap tests. (Grade of Recommendation: B, based on moderate quality cohort studies.) en
dc.language.iso en_US en
dc.publisher Family Physicians Inquiries Network en
dc.relation.ispartof Clinical Inquiries, 2001 (MU) en
dc.subject cancer screening en
dc.subject vaginal cancer en
dc.subject.lcsh Gynecology en
dc.subject.lcsh Hysterectomy en
dc.subject.lcsh Pap Test en
dc.subject.lcsh Generative organs, Female -- Cancer en
dc.subject.lcsh Medical screening en
dc.title Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease? en
dc.type Article en
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network


This item appears in the following Collection(s)

[-] show simple item record